Results of the EVOLVE trial reported at TCT 2011 PhysOrg.com "These results support the safety and efficacy of the novel abluminal bioabsorbable polymer everolimus-eluting stent for the treatment of patients with de novo coronary artery disease. Additional research is needed to evaluate clinical event rates and ... Results of the TWENTE trial reported at TCT 2011 |
